Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Hanley

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Diabetes Care|March 29, 2002
Association of parity with risk of type 2 diabetes and related metabolic disordersAnthony J G Hanley, Gail McKeown-Eyssen, Stewart B Harris, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentrationAnthony J G Hanley, Gail McKeown-Eyssen, Stewart B Harris, et al.
Diabetes Care|September 1, 2010
Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)Carlos Lorenzo, Lynne E Wagenknecht, Marian J Rewers, et al.
Lancet (London, England)|July 8, 2010
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled studyBernard Zinman, Stewart B Harris, Jan Neuman, et al.
Diabetologia|March 22, 2005
Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implicationsR Retnakaran, A J G Hanley, N Raif, et al.
Diabetes|May 27, 2003
Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetesAndré Carpentier, Bernard Zinman, Nathalie Leung, et al.
Diabetes|September 28, 2004
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis studyAnthony J G Hanley, Ken Williams, Andreas Festa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis StudyNels C Olson, Peter W Callas, Anthony J G Hanley, et al.
Diabetes Care|August 6, 2011
Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family StudyAnthony J G Hanley, Lynne E Wagenknecht, Jill M Norris, et al.
Journal of Lipid Research|January 20, 2009
Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetesPhilip W Connelly, Bernard Zinman, Graham F Maguire, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Diabetes Care|March 29, 2002
Association of parity with risk of type 2 diabetes and related metabolic disordersAnthony J G Hanley, Gail McKeown-Eyssen, Stewart B Harris, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentrationAnthony J G Hanley, Gail McKeown-Eyssen, Stewart B Harris, et al.
Diabetes Care|September 1, 2010
Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)Carlos Lorenzo, Lynne E Wagenknecht, Marian J Rewers, et al.
Lancet (London, England)|July 8, 2010
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled studyBernard Zinman, Stewart B Harris, Jan Neuman, et al.
Diabetologia|March 22, 2005
Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implicationsR Retnakaran, A J G Hanley, N Raif, et al.
Diabetes|May 27, 2003
Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetesAndré Carpentier, Bernard Zinman, Nathalie Leung, et al.
Diabetes|September 28, 2004
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis studyAnthony J G Hanley, Ken Williams, Andreas Festa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis StudyNels C Olson, Peter W Callas, Anthony J G Hanley, et al.
Diabetes Care|August 6, 2011
Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family StudyAnthony J G Hanley, Lynne E Wagenknecht, Jill M Norris, et al.
Journal of Lipid Research|January 20, 2009
Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetesPhilip W Connelly, Bernard Zinman, Graham F Maguire, et al.
Pageof 12